Lunit Inc. · KRX:328130

Lunit — Fact Sheet (April 2026)

2 slides from Lunit's fact sheet, April 2026

  1. Slide 1: Universal Immunohistochemistry Quantification

    © Lunit SCOPE’ ulHC Universal Immunohistochemistry Quantification Advance your IHC biomarker strategy with digital pathology X Al analysis Applications Description + Artificial Intelligence (Al)-based digital pathology CDx development image analysis software for next-gen IHC biomarkers » Access any

  2. Slide 2: Pioneering AI-Driven Biomarker Strategy Across Drug Development Phases

    Lunit SCOPE’ For Research Use Only Not for use in diagnostic procedure or decisions Pioneering Al-Driven Biomarker Strategy Across Drug Development Phases CDx development for next-gen IHC biomarkers Subcellular localization (Nucleus, Cytoplasm, Membrane) Continuous scoring (0-100%) Distance / margin

Lunit — Fact Sheet (April 2026) on 6ix